Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics.
Samradhi Singh, Namrata Pal, Swasti Shubham...
https://pubmed.ncbi.nlm.nih.gov/36835989Actively Recruiting
Led by Jinnah Postgraduate Medical Centre · Updated on 2026-02-10
116
Participants Needed
1
Research Sites
1 weeks
Total Duration
Researchers are evaluating the effects of a new herbal formulation called Melats P for women with Polycystic Ovarian Syndrome (PCOS), a common metabolic disorder affecting women of childbearing age. PCOS causes problems such as hormonal imbalance, irregular ovulation, infertility, obesity, excessive hair growth, acne, and metabolic issues like insulin resistance and type 2 diabetes. This study aims to compare the herbal formulation against conventional treatment and their combination in improving infertility and menstrual cycle regulation in women with PCOS. Participants will be divided into three groups: one receiving the herbal formulation Melats P at 500 mg twice daily, another receiving Metformin XR 750 mg twice daily, and a third group receiving both treatments together. Each treatment is given for 4 months. The herbal formulation contains plant-based ingredients chosen for their potential to restore hormonal balance and improve ovulation with fewer side effects compared to standard drugs. The study includes a phase 1 clinical trial design with randomized assignment and no masking. During the study, participants will have their menstrual cycle regulation monitored from baseline to 4 months. Additional assessments include blood tests for hormones such as follicle-stimulating hormone (FSH), luteinizing hormone (LH), and testosterone, as well as metabolic measures like glycated hemoglobin (HbA1c), fasting insulin levels, insulin resistance (HOMA-IR), and body weight. These evaluations will occur at the start and after 4 months of treatment to assess safety and effectiveness. The total participation duration is approximately 4 months, with the study scheduled to start in February 2025 and end by March 2026.
CONDITIONS
Clinical Investigation of Herbal Formulation and Its Efficacy in Polycystic Ovarian Syndrome
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 months
Participants receive assigned medication—herbal formulation, metformin, or both—twice daily as treatment for PCOS.
Regular visits to monitor safety and effectiveness
Total: 1 location
1
Jinnah Postgraduate Medical Centre
Karachi, Sindh, Pakistan
Actively Recruiting
S
Saba Zubair, PhD Scholar
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Samradhi Singh, Namrata Pal, Swasti Shubham...
https://pubmed.ncbi.nlm.nih.gov/36835989Ritu Deswal, Vinay Narwal, Amita Dang...
https://pubmed.ncbi.nlm.nih.gov/33627974Helena J Teede, Marie L Misso, Michael F Costello...
https://pubmed.ncbi.nlm.nih.gov/30052961Arezoo Moini Jazani, Hamidreza Nasimi Doost Azgomi, Alireza Nasimi Doost Azgomi...
https://pubmed.ncbi.nlm.nih.gov/31741280Marsa Dastgheib, Reza Barati-Boldaji, Niki Bahrampour...
https://pubmed.ncbi.nlm.nih.gov/36523331Julie Brown, Cindy Farquhar
https://pubmed.ncbi.nlm.nih.gov/27976369Wendy M Wolf, Rachel A Wattick, Olivia N Kinkade...
https://pubmed.ncbi.nlm.nih.gov/30463276Kimia Motlagh Asghari, Seyed Aria Nejadghaderi, Mahasti Alizadeh...
https://pubmed.ncbi.nlm.nih.gov/35488014Farzana Arain, Nesreen Arif, Hafeez Halepota
https://pubmed.ncbi.nlm.nih.gov/26150870G L Jones, K Benes, T L Clark...
https://pubmed.ncbi.nlm.nih.gov/14747184